PAPER Saint-Aubert L, Barbeau EJ, Péran P, Nemmi F, Vervueren C, Mirabel H, Payoux P, Hitzel A, Bonneville F, Gramada R, Tafani M, Vincent C, Puel M, Dechaumont S, Chollet F, Pariente J
SEARCH RESULTS
330029 RESULTS
PAPER Galasko D, Golde TE, Scheltens P
Progress in Alzheimer's disease research circa 2013: Is the glass half empty or half full?
Alzheimers Res Ther. 2013 May 29;5(3):26. PubMed: 23731836PAPER Igeta H, Suzuki Y, Motegi T, Sasaki A, Yokoyama Y, Someya T
Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
Gen Hosp Psychiatry. 2013 Jun 2; PubMed: 23731891PAPER Dhikav V, Singh P, Anand KS
Medication adherence survey of drugs useful in prevention of dementia of Alzheimer's type among Indian patients.
Int Psychogeriatr. 2013 Sep;25(9):1409-13. PubMed: 23731967PAPER Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, Sablonnière B, Romon-Rousseaux M, Buée L, Destée A, Godefroy O, Dürr A, Landwehrmeyer B, , Bachoud-Levi AC, Richard F, Blum D, Krystkowiak P
Association between caffeine intake and age at onset in Huntington's disease.
Neurobiol Dis. 2013 Oct;58:179-82. PubMed: 23732677PAPER Guan X, Yang J, Gu H, Zou J, Yao Z
Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease.
Hum Vaccin Immunother. 2013 May 31;9(8) PubMed: 23732905PAPER Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.
CNS Drugs. 2013 Jun;27(6):469-78. PubMed: 23733403PAPER Moriguchi S, Tanaka T, Narahashi T, Fukunaga K
Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.
Hippocampus. 2013 Jun 3; PubMed: 23733502PAPER Yamaguchi H, Shen J
Histological analysis of neurodegeneration in the mouse brain.
Methods Mol Biol. 2013;1004:91-113. PubMed: 23733572PAPER Ferencz B, Laukka EJ, Lövdén M, Kalpouzos G, Keller L, Graff C, Wahlund LO, Fratiglioni L, Bäckman L
The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age.
Front Hum Neurosci. 2013;7:198. PubMed: 23734114PAPER Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, Haass C, Bartenstein P
Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
J Nucl Med. 2013 Jul;54(7):1127-34. PubMed: 23729696PAPER Hernandes MS, Britto LR
NADPH oxidase and neurodegeneration.
Curr Neuropharmacol. 2012 Dec;10(4):321-7. PubMed: 23730256PAPER Benedictus MR, Goos JD, Binnewijzend MA, Muller M, Barkhof F, Scheltens P, Prins ND, van der Flier WM
Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease.
Neurobiol Aging. 2013 Nov;34(11):2488-94. PubMed: 23731952PAPER Xie Z, McAuliffe S, Swain CA, Ward SA, Crosby CA, Zheng H, Sherman J, Dong Y, Zhang Y, Sunder N, Burke D, Washicosky KJ, Tanzi RE, Marcantonio ER
Cerebrospinal Fluid Aβ to Tau Ratio and Postoperative Cognitive Change.
Ann Surg. 2013 Aug;258(2):364-369. PubMed: 23732272PAPER Choi J, Myung W, Chung JW, Kang HS, Na DL, Kim SY, Lee JH, Han SH, Choi SH, Kim S, Carroll BJ, Kim DK
Association between functional impairment, depression, and extrapyramidal signs in neuroleptic-free patients with Alzheimer disease.
J Geriatr Psychiatry Neurol. 2013 Sep;26(3):144-50. PubMed: 23733855Current Filters
No filters selected